Table 4. Adjusted Mean LDL-c and HDL-c Levels by Menopausal Status, ARIC.
Pre-/Perimenopausal | Postmenopausal | Difference in Means | P-value for Interaction | |
---|---|---|---|---|
LDL-c, mg/dL | ||||
Apolipoprotein E | ||||
ε22/ε23 | 105.9 ± 1.75 | 116.0 ± 1.19 | 10.1 | 0.47 |
ε34/ε44 | 130.6 ± 1.25 | 138.4 ± 0.86 | 7.8 | |
ε33 | 124.1 ± 0.88 | 132.0 ± 0.60 | 7.9 | |
HDL-c, mg/dL | ||||
Cholesteryl Ester | ||||
Transfer Protein | ||||
AA | 61.2 ± 0.70 | 60.6 ± 0.52 | -0.6 | 0.04 |
AG | 58.4 ± 0.42 | 57.6 ± 0.30 | -0.8 | |
GG | 54.9 ± 0.45 | 55.3 ± 0.33 | 0.4 | |
Hepatic Lipase | ||||
TT | 59.5 ± 0.89 | 59.6 ± 0.65 | 0.1 | 0.80 |
TC | 58.5 ± 0.46 | 58.2 ± 0.33 | -0.3 | |
CC | 56.6 ± 0.39 | 56.2 ± 0.29 | -0.4 | |
Lipoprotein | ||||
Lipase | ||||
GG/CG | 59.3 ± 0.63 | 59.6 ± 0.47 | 0.3 | 0.13 |
CC | 57.2 ± 0.32 | 56.6 ± 0.23 | -0.6 |
Values are mean (mg/dL) ± standard error across up to 4 ARIC visits.
Means are adjusted for visit, age, a combined center/race variable, body mass index, smoking, use of cholesterol lowering medications, and use of hormone replacement therapy.